Clinical Trial Update: Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive intra-arterial TNK and albumin after thrombectomy in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Albumin
• TNK (tenecteplase)

Snippet

Sponsor: Tianjin Huanhu Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN